Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel

NCT01202799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: 2% w/w diclofenac sodium topical gel
DRUG: 1.5% w/w diclofenac sodium topical solution
DRUG: 75 mg diclofenac sodium delayed release tablet

Sponsor

Mallinckrodt